Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities – Role of gut microbiota dysbiosis
Sofia Viana, Sara Nunes, Flávio Reis
Ageing Research Reviews (2020) Vol. 62, pp. 101123-101123
Open Access | Times Cited: 170

Showing 1-25 of 170 citing articles:

Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19
Rakhee K. Ramakrishnan, Tarek Kashour, Qutayba Hamid, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 215
Microbiota Modulation of the Gut-Lung Axis in COVID-19
Gislane Lelis Vilela de Oliveira, Camilla N. S. Oliveira, Camila Figueiredo Pinzan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 187
Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
Fen Zhang, Raphaela Iris Lau, Qin Liu, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 5, pp. 323-337
Open Access | Times Cited: 173
Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions
Bin Wang, Lei Zhang, Yongqiang Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 149
Mucosal immune response in biology, disease prevention and treatment
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role
Ahmad Ud Din, Maryam Mazhar, Muhammad Waseem, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110947-110947
Open Access | Times Cited: 112
Diet, Gut Microbiota and COVID-19
Praveen Rishi, Khem Raj, Shania Vij, et al.
Indian Journal of Microbiology (2020) Vol. 60, Iss. 4, pp. 420-429
Open Access | Times Cited: 101
Biomarkers of Post-COVID Depression
Piotr Lorkiewicz, Napoleon Waszkiewicz
Journal of Clinical Medicine (2021) Vol. 10, Iss. 18, pp. 4142-4142
Open Access | Times Cited: 87
Aging & COVID-19 susceptibility, disease severity, and clinical outcomes: The role of entangled risk factors
Melina Farshbafnadi, Sara Kamali Zonouzi, Mohammadmahdi Sabahi, et al.
Experimental Gerontology (2021) Vol. 154, pp. 111507-111507
Open Access | Times Cited: 80
A cross-talk between gut microbiome, salt and hypertension
Salma Naqvi, Turky Omar Asar, Vikas Kumar, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 134, pp. 111156-111156
Open Access | Times Cited: 74
Altered tryptophan absorption and metabolism could underlie long-term symptoms in survivors of coronavirus disease 2019 (COVID-19)
İmdat Eroğlu, Burcu Çelik Eroğlu, Gülay Sain Güven
Nutrition (2021) Vol. 90, pp. 111308-111308
Open Access | Times Cited: 74
Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study
Giancarlo Ceccarelli, Cristian Borrazzo, Claudia Pinacchio, et al.
Frontiers in Nutrition (2021) Vol. 7
Open Access | Times Cited: 70
Gut microbiota and renin-angiotensin system: a complex interplay at local and systemic levels
Kinga Jaworska, Mateusz Koper, Marcin Ufnal
AJP Gastrointestinal and Liver Physiology (2021) Vol. 321, Iss. 4, pp. G355-G366
Open Access | Times Cited: 64
Algae-Derived Bioactive Molecules for the Potential Treatment of SARS-CoV-2
Md. Asraful Alam, Roberto Parra‐Saldívar, Muhammad Bilal, et al.
Molecules (2021) Vol. 26, Iss. 8, pp. 2134-2134
Open Access | Times Cited: 57
Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19
Byungchang Jin, Rajan Singh, Se Eun Ha, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 19, pp. 2341-2352
Open Access | Times Cited: 55
Crosstalk Between the Gut Microbiota and Epithelial Cells Under Physiological and Infectious Conditions
An Zhou, Yi Yuan, Min Yang, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 47
Microbiota and COVID-19: Long-term and complex influencing factors
Jiaqi Gang, Haiyu Wang, Xiangsheng Xue, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 45
Current Status of Probiotics as Supplements in the Prevention and Treatment of Infectious Diseases
Xinquan Li, Qiang Wang, Xiafen Hu, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 37
Pathogenesis and Mechanisms of SARS-CoV-2 Infection in the Intestine, Liver, and Pancreas
Zaid Khreefa, Mallory T. Barbier, Ali Rıza Köksal, et al.
Cells (2023) Vol. 12, Iss. 2, pp. 262-262
Open Access | Times Cited: 25
Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications
Siva Sundara Kumar Durairajan, Abhay Singh, Udhaya Bharathy Saravanan, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1231-1231
Open Access | Times Cited: 22
Fucoidan from Ascophyllum nodosum and Undaria pinnatifida attenuate SARS-CoV-2 infection in vitro and in vivo by suppressing ACE2 and alleviating inflammation
Fang‐Shu Shi, Yvhao Xie, Yong‐Le Yang, et al.
Carbohydrate Polymers (2024) Vol. 332, pp. 121884-121884
Closed Access | Times Cited: 11
ACE2 mediates tryptophan alleviation on diarrhea by repairing intestine barrier involved mTOR pathway
J. Li, Yingli Yan, Yang Fu, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 7
Gut Microbiota Dysbiosis–Immune Hyperresponse–Inflammation Triad in Coronavirus Disease 2019 (COVID-19): Impact of Pharmacological and Nutraceutical Approaches
Carolina Ferreira, Sofia Viana, Flávio Reis
Microorganisms (2020) Vol. 8, Iss. 10, pp. 1514-1514
Open Access | Times Cited: 65
Biological and Clinical Factors Contributing to the Metabolic Heterogeneity of Hospitalized Patients with and without COVID-19
Angelo D’Alessandro, Tiffany Thomas, Imo J. Akpan, et al.
Cells (2021) Vol. 10, Iss. 9, pp. 2293-2293
Open Access | Times Cited: 45
Gut Dysbiosis and IL-21 Response in Patients with Severe COVID-19
Mahejibin Khan, Bijina J. Mathew, Priyal Gupta, et al.
Microorganisms (2021) Vol. 9, Iss. 6, pp. 1292-1292
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top